Ghrelin's triple mechanism — GH release, appetite stimulation, and direct cardiac/pulmonary protection — makes it uniquely suited for treating cachexia (muscle wasting) in heart failure and chronic lung disease.
Key findingGhrelin addresses cardiopulmonary cachexia through triple mechanism: GH-mediated anabolism, appetite stimulation to reverse wasting, and direct cardia
What the researchers found
Ghrelin addresses cardiopulmonary cachexia through triple mechanism: GH-mediated anabolism, appetite stimulation to reverse wasting, and direct cardiac/pulmonary tissue protection — the most comprehensive single-agent approach to this devastating complication.
Why it matters
Relevant for ghrp, cardiovascular, muscle-recovery.
How the study worked
review study on ghrp, cardiovascular.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2006.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.
Internal medicine (Tokyo, Japan), 45(3), 127-34
Citation
Nagaya, Noritoshi; Kojima, Masakazu; Kangawa, Kenji. (2006). Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.. Internal medicine (Tokyo, Japan), 45(3), 127-34.